cough
play
import
role
rapid
spread
influenza
infect
among
human
influenza
virusborn
bioparticl
discharg
infect
person
cough
transmit
uninfect
person
howev
whether
influenza
viru
particl
directli
transmit
target
host
larg
droplet
inhal
host
small
airborn
particl
remain
controversi
exampl
brankston
et
al
tellier
review
mani
clinic
epidemiolog
studi
well
experiment
transmiss
studi
use
anim
model
volunt
drew
strikingli
differ
conclus
brankston
et
al
support
airborn
rout
wherea
tellier
advoc
import
airborn
rout
natur
transmiss
influenza
infect
address
controversi
wong
et
al
conduct
spatiotempor
analysi
influenza
outbreak
hospit
ward
report
infect
spread
along
direct
airflow
index
case
furthermor
lindsley
et
al
blacher
et
al
detect
airborn
viru
healthcar
facil
treat
influenza
patient
thu
import
assess
airborn
transmiss
discern
amount
viru
releas
environment
air
cough
recent
viral
rna
detect
voluntari
cough
sampl
influenza
patient
mani
research
use
method
exampl
stelzerbraid
et
al
use
continu
posit
airway
pressur
mask
collect
disk
compos
dielectr
materi
lindsley
et
al
use
biosampl
skc
inc
eighti
four
pa
usa
twostag
bioaerosol
cyclon
sampler
nation
institut
occup
safeti
health
pittsburgh
pa
usa
moreov
bischoff
et
al
collect
virus
sampl
room
air
min
use
andersen
impact
air
sampler
thermo
fisher
scientif
waltham
usa
place
close
patient
milton
et
al
use
selfproduc
gii
sampler
design
collect
exhal
breath
cough
howev
system
use
aforement
studi
appear
optim
collect
sampl
mani
subject
medic
set
common
area
issu
burden
patient
portabl
simplic
present
studi
develop
portabl
system
easili
collect
bioparticl
releas
cough
bedsid
within
short
time
without
burden
patient
figur
quantifi
viral
load
definit
recoveri
rate
methodolog
collect
result
influenza
case
variou
condit
statu
vaccin
antivir
treatment
well
possibl
applic
analys
effect
intervent
discuss
furthermor
combin
viral
load
data
cough
sampl
throat
swab
oral
secret
propos
interest
possibl
regard
anatom
site
virus
might
mix
cough
studi
approv
ethic
committe
sendai
medic
center
sendai
citi
miyagi
prefectur
japan
written
inform
consent
obtain
patient
airborn
particl
cough
mist
gener
laboratori
experi
simul
cough
collect
use
airborn
particlesampl
unit
compos
portabl
air
sampler
airscan
sartoriu
ag
germani
connect
flexibl
polyvinyl
chlorid
hose
reinforc
end
inner
diamet
mm
length
sartoriu
ag
figur
gelatin
membran
filter
diamet
cm
pore
size
sartoriu
ag
figur
c
equip
coneshap
megaphonelik
devic
length
cm
entranc
diamet
cm
made
polycarbon
resin
sheet
figur
b
guid
airflow
membran
outer
surfac
devic
coat
aluminum
foil
reduc
static
electr
charg
inner
surfac
cough
throat
swab
oral
sampl
collect
order
individu
exhibit
symptom
influenza
visit
one
three
medic
facil
sendai
citi
japan
among
receiv
final
diagnosi
influenza
viral
isol
throat
swab
sampl
enrol
studi
sampl
patient
sendai
medic
center
averag
age
year
japan
selfdefens
forc
sendai
hospit
averag
age
year
shoji
clinic
age
year
collect
januari
februari
includ
analysi
sampl
collect
patient
ask
cough
voluntarili
approxim
time
pace
without
great
effort
cone
entranc
toward
gelatin
membran
filter
oppos
tip
cone
connect
sampler
set
constant
airflow
rate
maximum
pump
rate
accord
manufactur
previous
adopt
swine
influenza
studi
pump
durat
min
start
cough
continu
least
min
last
cough
filter
trap
bioparticl
cool
immedi
collect
transport
laboratori
dissolv
ml
eagl
minimum
essenti
medium
mem
sigmaaldrich
st
loui
mo
usa
supplement
u
penicillin
streptomycin
sampl
aliquot
assess
use
plaqu
assay
wherea
remain
sampl
store
quantif
viral
gene
copi
number
throat
swab
collect
pharyng
wall
exclus
one
investig
eh
avoid
technic
variat
sampl
techniqu
multipl
collector
use
cotton
swab
swab
vigor
wash
mem
transport
medium
supplement
u
penicillin
streptomycin
oral
secret
consist
mainli
saliva
mucu
produc
oral
membran
andor
mucu
brought
cough
deeper
respiratori
tract
spat
patient
petri
dish
influenza
viru
propag
allanto
caviti
fertil
chicken
egg
allanto
fluid
contain
virus
harvest
atom
simul
experi
use
electr
compressor
nebul
omron
kyoto
japan
gelatin
membran
dissolv
ml
mem
treat
collagenas
collagenas
nitta
gelatin
osaka
japan
h
ultracentrifug
g
min
obtain
viral
precipit
dissolv
extract
buffer
includ
rna
extract
kit
qiaamp
viral
rna
mini
kit
qiagen
valencia
ca
usa
viral
rna
extract
rnasefre
water
accord
manufactur
instruct
rna
solut
concentr
use
freezedri
system
compos
freez
dryer
eyela
tokyo
rikakikai
co
ltd
tokyo
japan
centrifug
concentr
taitec
saitama
japan
vacuum
pump
mfg
hitachi
tokyo
japan
total
amount
extract
rna
use
complementari
dna
cdna
synthesi
use
revers
transcript
kit
highcapac
cdna
revers
transcript
kit
appli
biosystem
foster
citi
ca
usa
random
primer
follow
manufactur
protocol
amount
gener
cdna
measur
quantit
realtim
revers
transcriptasepolymeras
chain
reaction
qrtpcr
use
miniopticon
system
cfx
manag
softwar
biorad
laboratori
hercul
ca
usa
influenza
matrix
protein
specif
primer
probe
design
daum
et
al
reaction
perform
plate
duplic
triplic
standard
curv
gener
serial
dilut
rna
cdna
influenza
viru
strain
neg
control
without
templat
includ
plate
throat
swab
sampl
mem
transport
medium
centrifug
lowspe
g
min
inocul
onto
madindarbi
canin
kidney
mdck
cell
viral
cultur
viral
isol
assess
within
week
identifi
specif
cytopath
effect
dissolv
membran
specimen
contain
virus
cough
serial
dilut
mem
inocul
onto
mdck
cell
dilut
specimen
assess
activ
virus
use
convent
plaqu
assay
within
h
collect
collect
system
equip
portabl
air
sampler
unit
contain
gelatin
membran
filter
larg
coneshap
megaphonelik
devic
guid
expel
particl
filter
figur
b
length
maximum
diamet
cone
cm
respect
base
inform
cough
airflow
provid
schlieren
german
word
indic
optic
inhomogen
analysi
per
report
tang
et
al
recent
studi
vector
analysi
two
report
estim
rang
momentum
cough
approxim
cm
less
particip
mouth
thereaft
particl
spread
diffus
consid
assumpt
length
devic
determin
cm
includ
possibl
outlier
case
particl
veloc
cough
slow
filter
least
less
suction
airflow
ms
theoret
calcul
evalu
effici
system
measur
total
viral
load
cough
attempt
separ
estim
rough
recoveri
rate
collect
quantif
process
collect
process
experi
simul
human
cough
perform
use
nebul
size
distribut
pattern
particl
confirm
mostli
resembl
mist
nebul
human
cough
figur
first
viral
fluid
contain
approxim
plaqu
form
unit
pfu
ml
influenza
viru
atom
nebul
everi
repeat
time
direct
toward
gelatin
membran
filter
set
cm
nebul
gener
viral
mist
drawn
directli
gelatin
filter
membran
appar
robust
pump
sampler
confirm
black
paper
background
visibl
nake
eye
similar
experi
repeat
use
hollow
paper
tube
length
cm
inner
diamet
cm
guid
mist
membran
outer
inner
surfac
coat
aluminum
foil
prevent
static
charg
figur
tube
place
minim
possibl
collect
mist
membran
might
drastic
reduc
diffus
mist
result
compar
experi
conduct
without
use
tube
coneshap
devic
employ
cough
collect
attach
nebul
place
entranc
devic
viral
mist
collect
experi
repeat
figur
b
observ
gener
mist
smoothli
suck
coneshap
devic
mist
collect
gelatin
membran
dissolv
mem
viral
gene
copynumb
quantifi
use
qrtpcr
result
show
recoveri
rate
virus
control
without
tube
almost
equal
result
system
employ
coneshap
devic
approxim
control
obtain
similar
result
less
concentr
viral
fluid
pfuml
atom
tabl
estim
recoveri
rate
quantif
process
measur
amount
viral
rna
step
tabl
briefli
viral
fluid
pour
gelatin
solut
compos
membran
dissolv
ml
mem
solut
treat
collagenas
digest
gelatin
prevent
regelatin
diminish
viscos
ultim
improv
effici
viral
condens
subsequ
ultracentrifug
step
viral
precipit
obtain
ultracentrifug
subject
rna
extract
concentr
freezedri
vacuumcentrifug
result
show
subtot
recoveri
rate
quantif
process
estim
total
recoveri
rate
system
appli
system
actual
clinic
set
collect
particl
cough
influenza
patient
whose
diagnosi
confirm
viral
isol
throat
swab
averag
patient
age
year
rang
year
sampl
patient
maletofemal
ratio
none
patient
signific
health
problem
fortyf
case
infect
influenza
viru
tabl
next
amount
viabl
viral
particl
trap
gelatin
membran
quantifi
use
convent
plaqu
assay
viabl
virus
detect
sampl
titer
pfu
per
cough
viral
subtyp
respect
due
potenti
exist
nonviabl
virion
qrtpcr
target
viral
gene
simultan
perform
detect
limit
reliabl
quantif
qrtpcr
system
preliminari
determin
gene
copi
per
cdna
influenza
viru
gene
calcul
dilut
rate
volum
membran
solut
time
cough
well
result
actual
case
determin
detect
limit
copi
per
cough
use
detect
limit
paramet
case
deem
either
posit
neg
presenc
influenza
viru
case
determin
posit
viral
load
vari
wide
copiescough
seventeen
sampl
contain
sever
dozen
copiescough
five
contain
copiescough
one
contain
except
high
level
ie
copiescough
remain
sampl
averag
median
copiescough
respect
standard
deviat
highest
viral
content
found
sampl
obtain
day
ill
patient
influenza
viru
infect
one
three
case
studi
activ
viru
detect
plaqu
count
result
analyz
differ
perspect
depend
characterist
individu
case
initi
graph
day
ill
along
abscissa
day
defin
onset
day
influenza
symptom
eg
high
fever
cough
find
signific
differ
viral
detect
rate
among
group
viral
subtyp
figur
tabl
influenza
season
tabl
figur
gender
tabl
moreov
find
specif
tendenc
relat
patient
bodi
temperatur
figur
infect
control
import
determin
presenc
absenc
vaccin
antivir
treatment
effect
viral
load
therefor
analyz
obtain
data
assess
impact
patient
vaccin
antivir
treatment
statu
viral
load
cough
among
case
receiv
influenza
vaccin
influenza
season
receiv
antivir
treatment
neuraminidas
na
inhibitor
oseltamivir
zanamivir
time
cough
collect
first
graph
viral
load
individu
case
along
state
antivir
treatment
time
treatment
initi
cough
collect
figur
plot
data
day
togeth
cluster
vaccin
antivir
treatment
statu
among
case
day
case
treat
supposedli
suffici
time
viral
replic
cough
collect
h
host
detect
rate
similar
among
control
untreat
case
vs
viral
load
p
fisher
exact
test
p
u
test
also
interest
result
patient
shorter
durat
treatment
h
perspect
whether
viral
releas
respiratori
tract
cough
could
inhibit
drug
administr
viral
bud
process
conclud
point
view
base
mechan
action
na
inhibitor
drug
time
action
consid
import
moment
viral
releas
viral
bud
site
inhibit
releas
inactiv
viral
na
enzym
thu
wish
determin
whether
anoth
mechan
drug
enhanc
rebind
viru
cell
surfac
alreadi
releas
cell
surfac
thu
reduc
viral
load
cough
therefor
ad
result
case
graph
found
viru
detect
rate
case
also
similar
untreat
suffici
treat
case
p
fisher
exact
test
viral
load
p
u
test
respect
howev
median
compar
shortterm
treat
case
show
signific
differ
untreat
case
suffici
treat
case
show
appar
smaller
viral
load
median
particlescough
respect
hand
analyz
case
receiv
antivir
treatment
statu
receiv
vaccin
season
vaccin
onset
season
influenza
epidem
subtyp
virus
detect
one
six
vaccin
case
four
six
control
unvaccin
case
viral
load
vaccin
case
lower
unvaccin
case
figur
result
suggest
vaccin
potenti
suppress
viral
spread
cough
although
margin
signific
differ
viral
load
viru
detect
rate
result
possibl
small
sampl
size
median
viral
load
without
vaccin
p
u
test
tendenc
similar
even
case
receiv
antivir
treatment
includ
analysi
median
viral
load
respect
p
u
test
figur
b
studi
cough
sampl
collect
patient
voluntari
cough
thought
would
import
determin
whether
symptom
cough
impact
actual
viral
load
cough
therefor
consid
cough
nonsymptomat
patient
eg
due
allergi
physiolog
stimul
caus
influenza
infect
viral
load
cough
sampl
collect
voluntari
cough
compar
influenza
case
without
symptom
cough
use
throat
swab
sampl
control
figur
viral
load
throat
swab
calcul
viral
load
transport
medium
approxim
quantiti
collect
swab
fluid
estim
increas
weight
cotton
swab
use
sampl
collect
base
tent
assumpt
specif
graviti
sampl
sampl
absorb
cotton
swab
almost
complet
wash
transport
medium
viral
load
cough
patient
symptom
cough
higher
without
median
respect
howev
differ
statist
signific
p
u
test
seen
throat
swab
median
respect
p
u
test
howev
interestingli
sever
patient
symptomat
group
higher
viral
load
nonsymptomat
group
addit
also
found
case
highest
viral
load
throat
swab
plot
number
undetect
level
virus
cough
sampl
thu
highest
viral
load
cough
sampl
plot
number
necessarili
correspond
highest
viral
load
throat
swab
figur
henc
result
suggest
viral
load
cough
sampl
least
case
might
affect
statu
symptom
cough
necessarili
directli
reflect
statu
viral
load
pharyng
wall
light
interest
result
investig
whether
viral
load
cough
sampl
collect
system
reflect
pharyng
wall
oral
secret
sourc
relat
viru
mainli
origin
plot
combin
viral
load
obtain
cough
sampl
throat
swab
oral
secret
individu
patient
twodimension
graph
examin
possibl
correl
figur
b
spearman
rank
correl
coeffici
also
calcul
combin
result
show
weak
correl
cough
samplesthroat
swab
rs
p
cough
samplesor
secret
rs
p
notabl
sever
case
show
almost
correl
high
viral
load
throat
swab
oral
secret
low
undetect
cough
sampl
vice
versa
figur
b
result
suggest
case
viru
collect
cough
least
case
highest
viral
load
low
viral
load
throat
swab
oral
sampl
viru
cough
might
origin
either
throat
wall
oral
caviti
main
object
studi
develop
simpl
portabl
system
collect
quantifi
viral
load
cough
aim
better
understand
airborn
infect
regard
conclud
system
perform
well
success
appli
actual
influenza
patient
system
employ
gelatin
membran
filter
trap
viral
particl
review
articl
aerosol
sampl
report
effici
physic
collect
gelatin
filter
airborn
particl
exceed
fabian
et
al
report
recoveri
rate
atom
viral
gene
use
gelatin
filter
optim
collect
system
use
skc
biosampl
rate
decreas
infecti
virus
present
studi
viabl
virus
detect
three
sampl
use
plaqu
assay
possibl
trap
virus
becam
inactiv
trap
gelatin
filter
assay
perform
overal
viral
gene
recoveri
rate
system
estim
approxim
suggest
actual
viral
load
cough
may
greater
actual
measur
amount
even
greater
took
account
possibl
undetect
loss
rna
extract
cdna
synthesi
design
cone
shape
megaphonelik
devic
adopt
length
cm
make
airflow
veloc
distal
end
cough
suction
speed
sampler
ensur
optim
airsampl
effici
howev
notic
reflect
flow
actual
case
stronger
cough
flow
might
collid
insid
wall
filter
membran
andor
intern
air
mass
devic
rebound
flush
intern
air
mass
howev
result
preliminari
experi
show
spill
caus
outward
flow
might
affect
result
volunt
smoker
cough
devic
chamber
one
breath
smoke
smoke
particl
count
adjac
outer
surfac
devic
lower
pump
without
data
shown
level
viral
gene
measur
cough
mani
patient
system
similar
measur
use
method
lindsley
et
al
perfectli
collect
cough
sampl
ask
patient
blow
spiromet
may
offer
support
evid
valid
collect
rate
system
furthermor
use
univers
primer
cdna
synthesi
viral
rna
aim
quantifi
rna
also
prepar
assess
influenza
b
case
studi
period
therefor
could
use
carrier
viru
ultracentrifug
process
combin
use
specif
primer
viral
target
carrier
virus
may
improv
viral
recoveri
howev
possibl
examin
futur
studi
particl
collect
method
may
suffici
distinguish
larg
droplet
directli
hit
membran
small
particl
droplet
nuclei
float
insid
cone
probabl
distanc
face
filter
may
long
enough
exclud
collect
larg
droplet
well
possibl
alreadi
taken
consider
method
aim
obtain
inform
regard
approxim
total
amount
viru
releas
cough
apart
issu
absolut
recoveri
rate
rel
comparison
viral
load
among
patient
may
possibl
highest
viral
load
copiescough
among
sampl
greater
averag
virusposit
sampl
possibl
factor
may
play
role
spread
infect
exist
socal
super
spreader
propos
epidem
sever
acut
respiratori
syndrom
influenza
moreov
lindsley
et
al
report
case
among
total
suspect
influenza
case
discharg
copiescough
bischoff
et
al
also
report
emitt
act
super
emitt
accord
ratio
propos
lloydsmith
et
al
measur
viral
load
cough
sampl
collect
influenza
patient
howev
limit
studi
regard
studi
subject
gener
healthi
young
adult
adolesc
data
young
children
elderli
person
person
chronic
medic
condit
limit
second
could
follow
time
cours
viral
shed
cough
among
individu
describ
applic
methodolog
studi
effect
vaccin
antivir
treatment
found
former
may
suppress
viral
releas
cough
latter
may
although
former
yet
support
statist
regard
antivir
treatment
care
taken
interpret
result
studi
case
treat
oseltamivir
infect
influenza
viru
influenza
season
consid
resist
drug
reflect
circul
viru
time
studi
howev
number
subject
includ
analys
small
may
insuffici
draw
conclus
correl
analys
viral
load
cough
throat
swab
oral
secret
sampl
show
viral
load
cough
may
necessarili
reflect
throat
swab
oral
secret
vice
versa
suggest
viru
collect
cough
least
case
signific
dispar
viral
load
level
two
kind
sampl
neither
origin
pharyng
wall
oral
caviti
thu
might
mix
cough
air
flow
anatom
deeper
site
respiratori
tract
site
regard
weak
correl
sampl
deni
possibl
certain
proport
case
viru
might
origin
throat
wall
oral
caviti
well
viru
cough
may
trap
throat
wall
andor
oral
caviti
detect
present
studi
measur
viral
load
mainli
genet
quantif
howev
optim
infect
control
inform
regard
activ
viru
import
detect
activ
virus
cough
sampl
moder
high
viral
titer
probabl
inactiv
virus
trap
gelatin
membran
plaqu
titrat
observ
virus
becom
inactiv
plaqu
titrat
conduct
within
short
time
trap
membran
may
becom
inactiv
extend
period
vari
degre
inactiv
speed
depend
environment
temperatur
humid
data
shown
result
indic
methodolog
might
insuffici
quantif
viabl
virus
altogeth
method
effect
appli
pointofcar
detect
influenza
virus
cough
quantif
nonetheless
largescal
studi
need
valid
result
involv
sever
import
epidemiolog
clinic
pathophysiolog
issu
